Grail's Slump Enters Week: Navigating Biotech's Setback
Grail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
Stay vigilant for fake initial coin offerings by examining whitepapers, token metrics, and regulatory disclosures to prevent losses.
17,900 articlesGrail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
A bold alliance between Allseas and a mining innovator aims to commercialize deep-sea nodule recovery. This strategic...
What makes a beaten-down stock worth a closer look? This article breaks down the signs, runs a hypothetical comeback ...
Amazon plans an unprecedented AI data-center buildout, with a $200 billion capex target for 2026. This article unpack...
A year ago, the idea that AI could tame inflation sounded compelling. Today, the same tech may be adding price pressu...
Non-QM mortgage products are expanding to serve gig workers and freelancers, signaling a major shift in access to hom...
NetApp stunned traders with a dramatic Friday rally after a stronger-than-expected earnings report. This guide breaks...
If the CLARITY Act clears Congress, crypto assets could be reclassified into three buckets, altering enforcement, lis...
Energy Select Sector SPDR Fund (XLE) has staged a rebound as crude hits higher levels. Two key signals could set the ...
Marvell Technology recently reached a new high, prompting questions about its staying power. This guide breaks down t...
Rackspace enters 2026 with a clearer path toward hybrid cloud leadership, but investors will scrutinize margins, cash...
Berkshire Hathaway’s massive cash pile has long frustrated investors. Now the company is finally putting some of that...